GAL and neoplasm: The present study presents a novel immunotherapy expressing α-gal epitopes using freshly obtained human PDAC tumor tissue homogenates from patients and provides a mechanism by which autologous PDAC tumor lysate vaccines may target APCs in situ using a natural anti-Gal Ab.